InvestorsHub Logo

ClosetInvestor

08/18/22 4:45 PM

#214003 RE: theswordman #214000

“Try asking which manuf wants to step up and make product when the last manuf is owed millions.”

There’s been chatter on the other boards about the recently written off leronlimab being used in future trails as a way to offset the loss.

What this chatter is not considering is that Samsung is in possession of the leronlimab and that they are owed $35 million for the product.

Tough spot for manufacturing to be in, especially when you consider Samsung is included in the CMC portion of the HIV BLA.